002644 Stock Overview
A pharmaceutical company, manufactures and sells traditional chinese medicines in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
LanZhou Foci Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.75 |
| 52 Week High | CN¥11.07 |
| 52 Week Low | CN¥5.84 |
| Beta | 0.22 |
| 11 Month Change | 15.89% |
| 3 Month Change | 36.72% |
| 1 Year Change | -18.45% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -20.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002644 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.9% | -1.5% | -2.1% |
| 1Y | -18.5% | -9.4% | 2.8% |
Return vs Industry: 002644 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.
Return vs Market: 002644 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 002644 volatility | |
|---|---|
| 002644 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002644 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002644's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1929 | 1,353 | n/a | www.fczy.com |
LanZhou Foci Pharmaceutical Co.,Ltd., a pharmaceutical company, manufactures and sells traditional chinese medicines in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gel under the Min Shan and Foci brands. It also engages in research and development of new herbal drugs.
LanZhou Foci Pharmaceutical Co.,Ltd. Fundamentals Summary
| 002644 fundamental statistics | |
|---|---|
| Market cap | CN¥4.47b |
| Earnings (TTM) | CN¥46.18m |
| Revenue (TTM) | CN¥988.75m |
96.8x
P/E Ratio4.5x
P/S RatioIs 002644 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002644 income statement (TTM) | |
|---|---|
| Revenue | CN¥988.75m |
| Cost of Revenue | CN¥664.76m |
| Gross Profit | CN¥323.99m |
| Other Expenses | CN¥277.82m |
| Earnings | CN¥46.18m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.09 |
| Gross Margin | 32.77% |
| Net Profit Margin | 4.67% |
| Debt/Equity Ratio | 2.1% |
How did 002644 perform over the long term?
See historical performance and comparison